Drug Safety Concerns Shape Manufacturing Policy

Jill Wechsler
Jill Wechsler

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Pharmaceutical Technology, Pharmaceutical Technology-03-02-2002, Volume 26, Issue 3

FDA wants manufacturers to revise product labeling and packaging and step up adverse-event monitoring to reduce risky product use.

Related Content:

Regulatory WatchPharmaceutical Technology-03-02-2002
Pandemic Highlights Need for Advanced Pharma Manufacturing
FDA and Industry Move to Renew New Drug User Fee Programs
FDA Documents Achievements and Plans for Future